O. S. BETTER; H. J. GURLAND; G. BRUNNER; E. HOFFER; T. M. S. CHANG; K. MAEDA; J. M. COURTNEY; R. MAINI; P. C. FARRELL; J. L. ROSENBAUM; M. C. GELFAND; S. SIDEMAN; A. GIMSON; U. TAITLEMAN; J. F. WINCHESTER
This content is PDF only. Please click on the PDF icon to access.
To the editor: The following summary prepared by participants in the recent International Workshop on Hemoperfusion held in Haifa, Israel, is submitted in response to the report by Lorch and Garella that appeared in the August 1979, issue (1).
Conservative medical management with support of vital systems represents the treatment of choice for most patients with toxic ingestions. For patients with serious intoxications fulfilling the following criteria, charcoal or resin hemoperfusion is indicated: [1] severe clinical intoxication leading to hypoventilation, hypothermia, hypotension, and nonresponsiveness despite supportive clinical measures; [2] lethal blood concentration of one or more potentially adsorbable drugs; and
BETTER OS, GURLAND HJ, BRUNNER G, et al. Controlled Trials of Hemoperfusion for Intoxication. Ann Intern Med. 1979;91:925. doi: https://doi.org/10.7326/0003-4819-91-6-925_2
Download citation file:
© 2019
Published: Ann Intern Med. 1979;91(6):925.
DOI: 10.7326/0003-4819-91-6-925_2